Anna Gamell
Overview
Explore the profile of Anna Gamell including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
29
Citations
230
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Pons-Tomas G, Martinez-de-Albeniz I, Rios-Barnes M, Gamell A, Simo-Nebot S, Balsells-Mejia S, et al.
Children (Basel)
. 2024 Sep;
11(9).
PMID: 39334627
Background: The objective of this study is to analyze the transplacental transmission of SARS-CoV-2 antibodies, their persistence in newborns, the factors that may influence this transmission, and the protection these...
2.
Noguera-Julian A, Gamell A, Ruggiu G, Cuso T, Latre C, Monsonis M, et al.
Arch Bronconeumol
. 2024 Aug;
PMID: 39095308
No abstract available.
3.
Gamell A, Velasco-Arnaiz E, Lopez-Ramos M, Rios-Barnes M, Simo-Nebot S, Fumado V, et al.
J Antimicrob Chemother
. 2024 Jul;
79(8):2062-2067.
PMID: 38958260
Introduction: Dalbavancin is an antibiotic active against most Gram-positive bacteria approved for acute bacterial skin and skin structure infections (ABSSSI). Owing to its long half-life, it is being increasingly used...
4.
Cobo-Vazquez E, Aguilera-Alonso D, Rello-Saltor V, Gamell A, Mellado-Sola I, Oltra-Benavent M, et al.
Pediatr Infect Dis J
. 2024 Jun;
PMID: 38916929
Central nervous system infections in children caused by group A Streptococcus are rare. This study, conducted across 52 hospitals in Spain from 2019 to 2023, identified 32 cases of central...
5.
de Arellano E, Saavedra-Lozano J, Villalon P, Jove-Blanco A, Grandioso D, Sotelo J, et al.
mSphere
. 2024 Mar;
9(3):e0072923.
PMID: 38440985
Importance: Group A (GAS) is a common bacterial pathogen in the pediatric population. In the last months of 2022, an unusual increase in GAS infections was detected in various countries....
6.
Agusti-Barjau C, Gamell A, De Sevilla M, Pons-Tomas G
Enferm Infecc Microbiol Clin (Engl Ed)
. 2023 Nov;
42(1):55-56.
PMID: 37968222
No abstract available.
7.
Soler-Garcia A, Gamell A, Monsonis M, Korta-Murua J, Espiau M, Rincon-Lopez E, et al.
Pediatr Infect Dis J
. 2023 Aug;
42(11):1017-1020.
PMID: 37566889
We studied 295 children (tuberculosis disease, n = 159; latent tuberculosis infection, n = 136) with positive QuantiFERON-TB Gold-Plus assay results. No significant differences between first and second antigen tube...
8.
Pereira L, Marco-Garcia M, Gamell A, Cuso T, Monsonis M, Latre C, et al.
Arch Bronconeumol
. 2023 Jun;
59(9):612-615.
PMID: 37385854
No abstract available.
9.
Gamell A, Latre C, Lopez-Ramos M, Noguera-Julian A
An Pediatr (Engl Ed)
. 2023 Jun;
99(2):150-151.
PMID: 37355456
No abstract available.
10.
Velasco-Arnaiz E, Batllori M, Monsonis M, Valls A, Rios-Barnes M, Simo-Nebot S, et al.
Sci Rep
. 2022 Nov;
12(1):19908.
PMID: 36402803
Interferon-gamma release assays performance can be impaired by host-related, technical and environmental factors, but data in young children are limited. We performed a cross-sectional study of children < 5 years-of-age...